Waklert Review: Is This Drug Worth Your Time?
Do you find yourself feeling overly tired throughout the day?
Is it difficult for you to stay focused on tasks that need to be completed?
Do you feel like you are in a perpetual fog most of the time?
If you answered yes to any of these questions, you may have considered taking a smart drug.
Because there are many wakefulness-promoting smart drugs on the market, individuals may find the process of choosing the right one to be difficult.
Waklert is a smart drug that promises to offer a greater level of alertness and improved cognitive function.
Everyone knows drugs do not always live up to their promises, so let’s delve a little deeper into this Waklert review to learn if this drug is worth the hype.
Waklert is a brand of Armodafinil that was created by Sun Pharmaceuticals, the same producer of Modalert. 
Armodafinil is the isolated R-enantiomer of Modafinil, the one that accounts for most positive effects. 
Modafinil has always been one of the most popular smart drugs on the market, though Armodafinil has recently risen in popularity and for good reason.
The following are some of the reasons users prefer Waklert over other brands of Modafinil:
There are a wide range of benefits from taking Waklert. Understanding these benefits encourages individuals to try this smart drug to see how it works for them.
Taking the proper dosage of a smart drug is crucial for getting the best results. Although the recommended dosage of Waklert is very similar to Modalert or Modvigil, there are some key differences.
When someone first starts taking Modafinil, the standard dosage is 200 milligrams. If you know anything about Armodafinil, you have likely heard the standard dosage is less, at 150 milligrams.
When you first begin taking Waklert, you will need to start at the recommended dosage of 150 milligrams. This dose will last in your system for about 8-12 hours before the positive benefits begin to fade. This is why so many people prefer Waklert over Modafinil or Modvigil because they are able to go to sleep at a normal time.
While some people are able to tolerate higher doses of Waklert, this is not for everyone.
Most people will function well at the recommended dose.
You should not take higher doses of Waklert unless you have plenty of experience taking smart drugs and know how you react to them.
You should not take this drug every day. Waklert should be taken no more than three times a week for the best results.
With its single enantiomer structure, Waklert generally does not cause the sleep and stomach issues Modafinil does.
As with any smart drug, there are some side-effects reported by users.
For most users, these fade over time and are not severe enough to cause individuals to stop taking Waklert:
As you can see from this Waklert review, this smart drug offers many benefits, but is it as powerful as Modafinil for providing alertness and improved cognitive focus?
It is important to note; Armodafinil is not quite as powerful as Modafinil, so it is not for everyone. Modafinil has a lengthier half-life, so its effects are felt longer.
For some people, this lengthier half-life is detrimental because it prevents them from being able to go to sleep when they are ready to rest.
The shorter half-life with Waklert allows individuals to get the sleep they need at night while being able to stay alert and focused during the day. 
So, the answer to the question of which is better is not a simple yes or no. Neither drug is superior to the other and which one is better really rests on the preferences of the user.
Those who need a longer half-life due to their demanding schedule may find Modafinil to be better able to meet their needs while those who need to be able to sleep normally will find Waklert to be superior.
If you are looking for a nootropic that will give you a purer “high” and a sustained 8-12 hours of alertness and focus, then Waklert may be for you.
We have found this drug to be extremely beneficial and we prefer it over Modafinil because it better meets our needs.
1. https://www.ncbi.nlm.nih.gov/pubmed/8977135 | The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor.
2. https://www.ncbi.nlm.nih.gov/pubmed/19663523 | Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives: analysis of data from three randomized, single-dose, pharmacokinetic studies.
3. https://www.tga.gov.au/sites/default/files/auspar-armodafinil-160526.pdf | Australian Public Assessment Report